BRCA2 and cancer: Considering the risk of cancer and the position of the mutation, for the BRCA1 gene, there was a central region in which the risk was lower (codons 374–1161), while for the BRCA2 gene, there was strong evidence for a region in which the risk decreased (codons 957–1827) and a region with increased risk (codons 2546–2968).